As of 2025-06-16, the Relative Valuation of Haemonetics Corp (HAE) is 95.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.09 USD, the upside of Haemonetics Corp based on Relative Valuation is 36.5%.
The range of the Relative Valuation is 70.16 - 122.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 35.2x | 28.2x |
| Forward P/E multiples | 18.0x - 29.7x | 23.8x |
| Fair Price | 70.16 - 122.86 | 95.69 |
| Upside | 0.1% - 75.3% | 36.5% |
| Date | P/E |
| 2025-06-13 | 20.08 |
| 2025-06-12 | 20.44 |
| 2025-06-11 | 20.49 |
| 2025-06-10 | 20.67 |
| 2025-06-09 | 20.53 |
| 2025-06-06 | 20.19 |
| 2025-06-05 | 20.17 |
| 2025-06-04 | 19.96 |
| 2025-06-03 | 19.96 |
| 2025-06-02 | 19.71 |
| 2025-05-30 | 19.40 |
| 2025-05-29 | 19.44 |
| 2025-05-28 | 19.37 |
| 2025-05-27 | 19.48 |
| 2025-05-23 | 18.93 |
| 2025-05-22 | 18.95 |
| 2025-05-21 | 19.17 |
| 2025-05-20 | 19.74 |
| 2025-05-19 | 19.87 |
| 2025-05-16 | 20.14 |
| 2025-05-15 | 19.88 |
| 2025-05-14 | 19.67 |
| 2025-05-13 | 19.81 |
| 2025-05-12 | 20.12 |
| 2025-05-09 | 19.54 |
| 2025-05-08 | 19.48 |
| 2025-05-07 | 18.41 |
| 2025-05-06 | 18.22 |
| 2025-05-05 | 17.90 |
| 2025-05-02 | 18.29 |
| 2025-05-01 | 18.05 |
| 2025-04-30 | 18.06 |
| 2025-04-29 | 18.33 |
| 2025-04-28 | 17.95 |
| 2025-04-25 | 17.91 |
| 2025-04-24 | 17.74 |
| 2025-04-23 | 17.29 |
| 2025-04-22 | 16.95 |
| 2025-04-21 | 16.33 |
| 2025-04-17 | 16.38 |
| 2025-04-16 | 16.30 |
| 2025-04-15 | 16.70 |
| 2025-04-14 | 17.02 |
| 2025-04-11 | 17.20 |
| 2025-04-10 | 16.98 |
| 2025-04-09 | 17.49 |
| 2025-04-08 | 16.06 |
| 2025-04-07 | 16.89 |
| 2025-04-04 | 17.44 |
| 2025-04-03 | 17.83 |